Northwestern Mutual Wealth Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-150
Closed -$806 3680
2023
Q1
$806 Buy
+150
New +$816 ﹤0.01% 3050
2020
Q4
Sell
-19
Closed -$1K 2928
2020
Q3
$1K Buy
+19
New +$982 ﹤0.01% 2487

Other funds holding ORTX

Northwestern Mutual Wealth Management's ORTX Position: Q2 2023 in Review

Northwestern Mutual Wealth Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2023, closing a stake of 150 shares — an estimated $806 sold.

Northwestern Mutual Wealth Management first reported a position in ORTX in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 33 funds tracked by Wall St. Rank hold ORTX as of Q2 2023.

  • Northwestern Mutual Wealth Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 150 Orchard Therapeutics plc American Depositary Shares shares in Q2 2023, an estimated $806.
  • Northwestern Mutual Wealth Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.